CW May 2004

category image Volume 13
Issue Number 5
May 2004
ISSN 10593802

Anticoagulant may Improve Late-stage Cancer Survival

Though the small molecular weight anticoagulant Fragmin (dalteperin), did not significantly improve the survival rate of advanced cancer patients, this drug did improve the survival in a subgroup of patients with a better prognosis.
Go to Previous Page
Go to Next Page

Source & Additional Reading

Journal of Clinical Oncology, May 15, 2004.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW May 2004

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login